GERD Journal Articles

• Antipsychotics Associated With Severe Asthma Exacerbation Risk Asthma patients receiving typical antipsychotic treatment may realize a higher risk of severe asthma exacerbations, but the effect may be dose related.
  BMC Pulmonary Medicine, April 27, 2022
• TLC599 in Patients With Osteoarthritis of the Knee TLC599, a newly developed injectable treatment, may be a safe and effective pain management option for knee osteoarthritis.
  Arthritis Research & Therapy, April 04, 2022
• PDE5 Inhibitors for ED After Radical Prostatectomy Erectile dysfunction is a known complication of nerve-sparing radical prostatectomy. Could postoperative PDE5 inhibitor treatment help?
  Translational Andrology and Urology, March 31, 2022
• Artificial Intelligence in the Diagnosis of Esophageal Diseases This review summarizes and evaluates the latest evidence for the use of AI in the diagnosis of both malignant and benign esophageal diseases.
  Alimentary Pharmacology & Therapeutics, March 22, 2022
• First-Year Follow-up of Chronic Nonbacterial Osteomyelitis What have we learned about the disease course of pediatric patients with chronic nonbacterial osteomyelitis?
  Arthritis Research & Therapy, January 19, 2022
• Effects of PPIs on Glycemic Control and Incident Diabetes Could PPI therapy potentially help improve glycemic control and decrease the risk for developing diabetes?
  Journal of Clinical Endocrinology & Metabolism, December 02, 2021
• Long-term Risk of Upper GI Bleeding After H. Pylori Eradication This study aimed to determine the long-term real-world benefits of H. pylori eradication in preventing non-variceal upper GI bleeding, stratified by age group.
  Alimentary Pharmacology & Therapeutics, November 23, 2021
• H. Pylori Infection, GERD, and Its Complications This review aimed to elucidate the association between H. pylori infection and GERD symptoms, erosive esophagitis, and Barrett's esophagus. Might H. pylori infection provide a protective effect?
  Alimentary Pharmacology & Therapeutics, November 03, 2021
• The Effects of Pregabalin vs Placebo on Functional Dyspepsia Might the gabapentinoid pregabalin be a safe and effective treatment option for functional dyspepsia?
  Alimentary Pharmacology & Therapeutics, November 01, 2021
• The Long-term Risk for MI or Stroke After PPI Therapy Some studies have suggested that PPI use increases long-term cardiovascular risk, but this analysis found no increased risk of MI or ischemic stroke in the first decade after PPI therapy.
  Alimentary Pharmacology & Therapeutics, October 27, 2021
• Family History and Risk of Barrett's Esophagus How much impact does family history have on the risk of developing Barrett's esophagus or esophageal adenocarcinoma?
  Alimentary Pharmacology & Therapeutics, October 18, 2021
• Prediction of PONV by Point-of-Care Gastric Ultrasound Could bedside ultrasound evaluation of the stomach in patients undergoing emergency abdominal surgery predict the risk of postoperative nausea and vomiting?
  BMC Anesthesiology, October 06, 2021
• Duodenogastroesophageal Reflux Prevalence and Treatment How prevalent is duodenogastroesophageal, or "bile", reflux, and what is its impact on GERD symptoms and esophageal lesions?
  Alimentary Pharmacology & Therapeutics, October 04, 2021
• Effects of Intragastric Balloon in NAFLD With Fibrosis Could intragastric balloon placement help improve liver fibrosis in obese NAFLD patients?
  Liver International, September 30, 2021
• GI, CV, Autonomic, Allergic Manifestations of Ehlers-Danlos A new study examines the prevalence of these manifestations among hospitalized Ehlers-Danlos syndrome patients and the potential impacts on outcomes.
  Rheumatology, September 29, 2021
• Polypharmacy and HIV Suppression in Older People With HIV Might the use of multiple medications impact HIV viral suppression among older adults?
  HIV Medicine, September 21, 2021
• Erectile Dysfunction in a Young Man After OTC Omeprazole Was the PPI omeprazole the cause of this young man's sudden erectile dysfunction?
  Journal of Medical Case Reports, September 08, 2021
• Chronic Use of Ranitidine and Gastrointestinal Malignancies Unacceptable levels of NDMA in ranitidine caused it to be removed it from the market. Do patients who took ranitidine have a higher risk of GI cancer compared with those on other anti-reflux drugs?
  Alimentary Pharmacology & Therapeutics, September 08, 2021
• Tegoprazan vs. Placebo in Non-erosive Reflux Disease Is tegoprazan, a novel, long-acting potassium-competitive acid blocker, superior to placebo in patients with non-erosive reflux disease?
  Alimentary Pharmacology & Therapeutics, August 30, 2021
• An Overview of Male Osteoporosis While osteoporosis is often thought of as a disease of postmenopausal women, it can affect men as well. Review the risk factors, causes, and management of male osteoporosis in this article.
  U.S. Pharmacist, August 25, 2021